Project Grant R01DA063623
Award Date 5/15/26
Completion Date 2/28/31
Dollars Obligated $570K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- Federal Grant Award Summary The University of Michigan received a $170,744 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective June 17, 2025, with a completion date of December 31, 2025. This research initiative investigates the glucocorticoid receptor (GR) as a neuromolecular mechanism underlying inhibitory control deficits associated with substance use disorder (SUD). The project examines how the GR...
- Federal Grant Award Summary Michigan State University, in partnership with Henry Ford Health, received a $183,681 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded on March 15, 2026. The project, titled "Patient-Engaged Development and Testing of a Technology-Based Intervention to Reduce Prenatal Cannabis Use," will deliver a comprehensive intervention system designed to address increasing cannabis use among...
- Federal Grant Award Summary The University of Michigan received a $595,171 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded May 1, 2026, with completion targeted for February 28, 2031. This research project investigates the functional anatomy, physiology, and behavioral responses mediated by mu opioid receptor (MOR) signaling on medial thalamic neurons. The research addresses a critical gap in understanding...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $529,990 to Michigan State University (operating as Henry Ford Health+Michigan State University Health Sciences) on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test an adaptive psychological intervention designed to reduce prolonged opioid use among hospitalized patients recovering from musculoskeletal injuries. The intervention employs a tiered approach...
- Federal Grant Award Summary Michigan State University (operating as Henry Ford Health + Michigan State University Health Sciences) received a $295,896 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) on March 15, 2026, with a completion date of February 29, 2028. This research project will develop and validate epigenetic risk scoring tools to assess polysubstance use (PSU) and associated comorbidities in people with HIV...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the Regents of the University of Michigan $172,144 through the Drug Use and Addiction Research Programs (CFDA 93.279) to support research on optimizing chemical- and light-dependent protein switches for controlling opioid peptide activity with temporal control. The grant, awarded on June 26, 2025, funds research designed to advance understanding of mu opioid receptor (MOR) mechanisms and their role in pain...
- Federal Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects Division, received a $1.4M Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to conduct a fully-powered randomized controlled trial evaluating a novel social media-based intervention for high-intensity drinking (HID) among emerging adults. Awarded on September 15, 2025, with a completion date of August...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the Regents of the University of Michigan $325,904 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop machine learning methods for real-time modeling and perturbation of stimulus-shaped neural manifolds. The project, which extends through December 31, 2028, will produce generalizable computational tools designed to construct low-dimensional neural manifolds shaped by...
- Federal Grant Award Summary The University of Maryland, College Park received a $107,090 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded February 15, 2026, with a completion date of February 14, 2028. This research initiative will generate longitudinal, person-centered data characterizing the interplay between perinatal substance use (PSU) and perinatal depression (PD) and their combined impact on infant...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a Project Grant of $386,301.00 to the Regents of the University of Michigan under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning May 1, 2026 and concluding February 28, 2031. This award supports basic neuroscience research investigating axonal mechanisms that regulate dopamine release in the striatum, with particular focus on understanding how striatal cholinergic interneurons modulate dopaminergic...